The US Pharmacopoeia (USP) will be ramping up its operations in India, according to KV Surendranath,The USP, a scientific non-profit organisation that sets standards for the identity, strength, quality, and purity of medicines, will be investing $200 million over next five years in consolidation of its operations.
While speaking to newspersons on the sidelines of a workshop for the Asia-Pacific chapter of the Network of Official Medicines Control Laboratories which began here on Tuesday, Surendranath said a part of this investment will also be spent in India.
The activities of the USP in India will increase including the work on medical monograph modernisation. “The future investment in India will mainly go into manpower, expansion of activities and technology,’’ he said.
Business Line
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…